Trial Profile
A Phase I, Randomised, Double-blind, Placebo-controlled, First-in-human study to evaluate the safety, tolerability, and pharmacokinetics of single- and multiple-ascending doses of ASP0819 in healthy adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Oct 2018
Price :
$35
*
At a glance
- Drugs ASP 0819 (Primary)
- Indications Fibromyalgia
- Focus Adverse reactions; First in man; Pharmacokinetics
- 10 Oct 2018 New trial record
- 16 Sep 2018 Results presented at the 17th World Congress on Pain